PTHS

AMEXStock

Pelthos Therapeutics Inc.

$25.05+1.80 (+7.74%)

52-Week Range

$16.18

$37.42

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

3.94

Volume

12.0K

Avg Volume

6.4K

Performance

+7.40%

+4.49%

-29.55%

YTD

-21.05%

+40.91%

Price Chart

ETF Exposure

PTHS is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	2	$82	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	91	$3K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$14	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	51,818	$1.2M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	272	$9K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	23	$764	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	12,996	$312K	$84.10B	0.05%

About PTHS ETF Exposure

Pelthos Therapeutics Inc. (PTHS) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $25.05. Investors can gain exposure to PTHS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PTHS, sorted by portfolio weight.